CLINICAL_TRIALS
trial_result
· 2025-02-20
Clinical Trial Update: A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses [Phase 4]
Summary
A Phase 4 study evaluating tirbanibulin for actinic keratosis has completed. Results from the trial have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Almirall, S.A. | Conditions: Actinic Keratosis | Phase 4 | Status: COMPLETED | Results posted: 2025-02-20